Welcome New Member: Swixx BioPharma d.o.o.

With the sales likely to exceed 600M € in 2022, Swixx BioPharma is already the largest agent for ethical pharmaceuticals serving research-based biopharma in CEE. Swixx BioPharma began operations in December 2014. Today, Swixx’ real differentiator is our 1,000+ employees, dedicating every day to provide modern medicines to patients in need, with an innovative mindset and dynamic company culture. The company has gathered under one roof a unique group of experienced managers and medical professionals with expertise in rare disease, oncology-haematology, specialty, and self-medication. We are a service-oriented, high quality and ethically driven company. Swixx BioPharma d.o.o. employs 60 highly educated professionals in Croatia. For more information about Swixx, please visit: www.swixxbiopharma.com